Clinical Trials Logo
  1. Home
  2. Human Papillomavirus (HPV)
  3. NCT03111251

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Human Papillomavirus (HPV) Clinical Trial

Official title:
Multi-component Interventions for Patients and Providers to Increase HPV Vaccination in a Network of Pediatric Clinics in Houston, TX

Clinical Trial Summary

The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination among male and female patients ages 11-17 in a large pediatric clinic network in the greater Houston area. The hypothesis is that HPV vaccine initiation will be higher in clinics randomized to the parent plus provider intervention compared with clinics randomized to the provider-only intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03111251
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact
Status Completed
Phase N/A
Start date March 1, 2015
Completion date February 28, 2019
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02540928 - AMG 319 in HPV Positive and Negative HNSCC Phase 2
Not yet recruiting NCT05727033 - Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections N/A
Withdrawn NCT04849377 - RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC Phase 2
Completed NCT02873741 - New Strategies to Assess Anal Cancer Risk In Women
Completed NCT01188850 - Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100 Phase 1
Completed NCT02524223 - Prevalence of HPV Transmission During Medically Assisted Procreation Procedures N/A
Completed NCT03180684 - Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) Phase 2
Recruiting NCT01197079 - Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years) N/A
Recruiting NCT05539638 - The Role of Circulating Tumour DNA in Head and Neck Cancer